MSB 1.34% $1.51 mesoblast limited

Ryoncil: ODAC/FDA Meeting Discussion, page-1589

  1. 3,149 Posts.
    lightbulb Created with Sketch. 1633
    Garcia . Yes. Thinks question was a little narrow. Not sure if better than other treatments but it does show efficacy.
    Halabi 51/49 to voting yes. Persuaded by clinical experts that not possible to do randomised trials. Hopeful MSB try to address concern... (mic dropped out)
    Hinrichs —- damn the audio has dropped out ... ahhh
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.